Altered cerebral protein synthesis in fragile X syndrome: Studies in human subjects and knockout mice

Journal of Cerebral Blood Flow and Metabolism

Volumn 33, Issue 4, 2013, Pages 499-507

  Qin, Mei ^a   Schmidt, Kathleen C ^a   Zametkin, Alan J ^a   Bishu, Shrinivas ^a   Horowitz, Lisa M ^a   Burlin, Thomas V ^a   Xia, Zengyan ^a   Huang, Tianjiang ^a   Quezado, Zenaide M ^b   Smith, Carolyn Beebe ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

brain; Fmr1 knockout mouse; leucine; positron emission tomography; propofol anesthesia; protein synthesis

Indexed keywords

CARBON 11; PROPOFOL;

ADULT; ARTICLE; BRAIN CORTEX; BRAIN REGION; CEREBELLUM; FRAGILE X SYNDROME; HUMAN; MOUSE; NERVE CELL; NERVE CONDUCTION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SEDATION; SYNAPTIC INHIBITION; WAKEFULNESS;

ADOLESCENT; ADULT; ANIMALS; BRAIN; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MICE; MICE, KNOCKOUT; POSITRON-EMISSION TOMOGRAPHY; PROPOFOL; PROTEIN BIOSYNTHESIS; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 84876416347     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2012.205     Document Type: Article

References (39)

1. Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti A et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991; 65: 905-914.
2. Darnell JC, Jensen KB, Jin P, Brown V, Warren ST, Darnell RB. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 2001; 107: 489-499.
3. Darnell JC, Mostovetsky O, Darnell RB. FMRP RNA targets: identification and validation. Genes Brain Behav 2005; 4: 341-349.
4. Ashley Jr CT, Wilkinson KD, Reines D, Warren ST. FMR1 protein: conserved RNP family domains and selective RNA binding. Science (NY) 1993; 262: 563-566.
5. Siomi H, Siomi MC, Nussbaum RL, Dreyfuss G. The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein. Cell 1993; 74: 291-298.
6. Feng Y, Gutekunst CA, Eberhart DE, Yi H, Warren ST, Hersch SM. Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J Neurosci 1997; 17: 1539-1547.
7. Li Z, Zhang Y, Ku L, Wilkinson KD, Warren ST, Feng Y. The fragile X mental retardation protein inhibits translation via interacting with mRNA. Nucleic Acids Res 2001; 29: 2276-2283.
8. Laggerbauer B, Ostareck D, Keidel EM, Ostareck-Lederer A, Fischer U. Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum Mol Genet 2001; 10: 329-338.
9. Zhang YQ, Bailey AM, Matthies HJ, Renden RB, Smith MA, Speese SD et al. Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function. Cell 2001; 107: 591-603.
10. Qin M, Kang J, Burlin TV, Jiang C, Smith CB. Postadolescent changes in regional cerebral protein synthesis: an in vivo study in the FMR1 null mouse. J Neurosci 2005; 25: 5087-5095.
11. Bolduc FV, Bell K, Cox H, Broadie KS, Tully T. Excess protein synthesis in Drosophila fragile X mutants impairs long-term memory. Nature Neurosci 2008; 11: 1143-1145.
12. 11C]leucine and PET with correction for recycling of tissue amino acids: I. Kinetic modeling approach. J Cereb Blood Flow Metab 2005; 25: 617-628.
13. 11C]leucine and PET with correction for recycling of tissue amino acids: II. Validation in rhesus monkeys. J Cereb Blood Flow Metab, 2005; 25: 629-640.
14. 11C]leucine and PET in conscious, young adult men: normal values, variability, and reproducibility. J Cereb Blood Flow Metab 2008; 28: 1502-1513.
15. 11C]leucine and PET in healthy male subjects. J Cereb Blood Flow Metab 2009; 29: 1035-1047.
16. First MB, Spitzer RL, Williams JB. Structured clinical interview for DSM-IV axis I disorders SCID-I: clinician version, administration booklet. American Psychiatric Pub 1997.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Revised 4th ed)Washington, DC, 2000.
18. Kaufman J, Birmaher B, Brent D, Rao U, Ryan N. The Schedule for Affective Disorders and Schizophrenia for School-Age Children. University of Pittsburgh Medical Center: Pittsburgh, PA, 1996.
19. Gan TJ, Glass PS, Windsor A, Payne F, Rosow C, Sebel P et al. Bispectral index monitoring allows faster emergence and improved recovery from propofol, alfentanil, and nitrous oxide anesthesia. Anesthesiology 1997; 87: 808-815.
20. Carson RE, Barker WC, Liow J-S, Johnson CA. Design of a motion-compensation OSEM list-mode algorithm for resolution-recovery reconstruction for the HRRT. IEEE Nucl Sci Symp Conf Rec 2003; 5: 3281-3285.
21. Wienhard K, Schmand M, Casey ME, Baker K, Bao J, Eriksson L et al. The ECAT HRRT: performance and first clinical application of the new high resolution research tomograph. IEEE Trans Nucl Sci 2002; 49: 104-110.
22. Fischer B, Modersitzki J. Intensity-based image registration with a guaranteed one-to-one point match. Methods Inf Med 2004; 43: 327-330.
23. 11C]leucine PET method for determination of regional rates of cerebral protein synthesis: validation and comparison with region-of-interest- based methods. J Cereb Blood Flow Metab 2009; 29: 1317-1331.
24. Smith CB, Deibler GE, Eng N, Schmidt K, Sokoloff L. Measurement of local cerebral protein synthesis in vivo: influence of recycling of amino acids derived from protein degradation. Proc Natl Acad Sci USA 1988; 85: 9341-9345.
25. Paxinos DG, Franklin KBJ. The Mouse Brain in Stereotaxic Coordinates. Academic Press: New York, NY, 2001.
26. 11C]leucine method for measurement of regional rates of cerebral protein synthesis with PET. J Cereb Blood Flow Metab 2008; 28: 1388-1398.
27. Reiss AL, Lee J, Freund L. Neuroanatomy of fragile X syndrome: the temporal lobe. Neurology 1994; 44: 1317-1324.
28. Gothelf D, Furfaro JA, Hoeft F, Eckert MA, Hall SS, O'Hara R et al. Neuroanatomy of fragile X syndrome is associated with aberrant behavior and the fragile X mental retardation protein (FMRP). Ann Neurol 2008; 63: 40-51.
29. Hallahan BP, Craig MC, Toal F, Daly EM, Moore CJ, Ambikapathy A et al. In vivo brain anatomy of adult males with fragile X syndrome: an MRI study. Neuroimage 2011; 54: 16-24.
30. Hollander E, Anagnostou E, Chaplin W, Esposito K, Haznedar MM, Llcalzi E et al. Striatal volume on magnetic resonance imaging and repetitive behaviors in autism. Biol Psychiatry 2005; 58: 226-232.
31. Buggy DJ, Nicol B, Rowbotham DJ, Lambert DG. Effects of intravenous anesthetic agents on glutamate release. Anesthesiology 2000; 92: 1067-1073.
32. Haeseler G, Karst M, Foadi N, Gudehus S, Roeder A, Hecker H et al. High-affinity blockade of voltage-operated skeletal muscle and neuronal sodium channels by halogenated propofol analogues. Br J Pharmacol 2008; 155: 265-275.
33. Eghbali M, Gage PW, Birnir B. Effects of propofol on GABA (A) channel conductance in rat cultured hippocampal neurons. Eur J Pharmacol 2003; 468: 75-82.
34. Kaisti KK, Langsjo JW, Aalto S, Oikonen V, Sipola H, Teras M et al. Effects of sevoflurane, propofol, and adjunct nitrous oxide on regional cerebral blood flow, oxygen consumption, and blood volume in humans. Anesthesiology 2003; 99: 603-613.
35. Dam M, Ori C, Pizzolato G, Ricchieri GL, Pellegrini A, Giron GP et al. The effects of propofol anesthesia on local cerebral glucose utilization in the rat. Anesthesiology 1990; 73: 499-505.
36. Chuang S-C, Zhao W, Bauchwitz R, Yan Q, Bianchi R, Wong RKS. Prolonged epi-leptiform discharges induced by altered group I metabotropic glutamate receptor-mediated synaptic responses in hippocampal slices of a fragile X mouse model. J Neurosci 2005; 25: 8048-8055.
37. Liu Z-H, Huang T, Smith CB. Lithium reverses increased rates of cerebral protein synthesis in a mouse model of fragile X syndrome. Neurobiol Dis 2012; 45: 1145-1152.
38. Aschrafi A, Cunningham BA, Edelman GM, Vanderklish PW. The fragile X mental retardation protein and group I metabotropic glutamate receptors regulate levels of mRNA granules in brain. Proc Natl Acad Sci USA 2005; 102: 2180-2185.
39. Osterweil EK, Krueger DD, Reinhold K, Bear MF. Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome. J Neurosci 2010; 30: 15616-15627.